Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001732369-26-000008

Options or other derivatives

  • CHIEF EXECUTIVE OFFICER acquired 317,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Seehra Jasbir CHIEF EXECUTIVE OFFICER 2026-02-24 Grant or award · Employee Stock Option (Right to Buy) +217,000 217,000 D: show line 1 in the form
Seehra Jasbir CHIEF EXECUTIVE OFFICER 2026-02-24 Grant or award · Employee Stock Option (right to buy) +100,000 100,000 D: show line 2 in the form
Loading xslF345X05/form4-02262026_040216.xml…